1
|
Versteegh H, Zandvliet MMJM, Feenstra LR, van der Steen FEMM, Teske E. Feline Lymphoma: Patient Characteristics and Response Outcome of the COP-Protocol in Cats with Malignant Lymphoma in The Netherlands. Animals (Basel) 2023; 13:2667. [PMID: 37627457 PMCID: PMC10451823 DOI: 10.3390/ani13162667] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2023] [Revised: 08/12/2023] [Accepted: 08/16/2023] [Indexed: 08/27/2023] Open
Abstract
Feline lymphoma is currently less commonly associated with retrovirus infections as the feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV). This is thought to have caused a shift in the distribution of anatomical subtypes and eventually have led to poorer treatment outcomes. The aim of this study was to evaluate whether this change was also notable in the Netherlands, a country historically known for its low prevalence of FeLV and FIV, and to determine its consequences on treatment response. A 10-year cohort of 174 cats with large cell lymphoma (110 treated) were included and compared to historical data from previously published reports in the Netherlands. Of the 90 cats screened, only one tested positive for FeLV and three for FIV. The most current cohort had an increased age (median 8.7 years) and fever Siamese cats (6.3%) compared to previous reports, with alimentary (24.5%) and nasopharyngeal lymphoma (22.7%) being the most common subtypes. Sixty-six of the one hundred and ten cats (60%) went into complete remission, (CR) resulting in a median disease-free period (DFP) of 763 days, with nasopharyngeal and mediastinal having the longest DFP. The median overall survival time was 274 days with an estimated 1-year survival of 41.3% and a 2-year survival of 34.6%, respectively. Patient characteristics of cats with malignant lymphoma in the Netherlands have changed over the years, but this cannot be explained by differences in FeLV/FIV prevalence. Although the overall response rate to therapy did not change over time, for some lymphoma subtypes, longer DFPs were observed compared to 30 years ago.
Collapse
Affiliation(s)
- Hannah Versteegh
- Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 108, 3584 CS Utrecht, The Netherlands; (M.M.J.M.Z.); (L.R.F.); (F.E.M.M.v.d.S.); (E.T.)
| | | | | | | | | |
Collapse
|
2
|
Parisi F, Fonti N, Millanta F, Freer G, Pistello M, Poli A. Exploring the link between viruses and cancer in companion animals: a comprehensive and comparative analysis. Infect Agent Cancer 2023; 18:40. [PMID: 37386451 DOI: 10.1186/s13027-023-00518-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2023] [Accepted: 06/16/2023] [Indexed: 07/01/2023] Open
Abstract
Currently, it is estimated that 15% of human neoplasms globally are caused by infectious agents, with new evidence emerging continuously. Multiple agents have been implicated in various forms of neoplasia, with viruses as the most frequent. In recent years, investigation on viral mechanisms underlying tumoral transformation in cancer development and progression are in the spotlight, both in human and veterinary oncology. Oncogenic viruses in veterinary medicine are of primary importance not only as original pathogens of pets, but also in the view of pets as models of human malignancies. Hence, this work will provide an overview of the main oncogenic viruses of companion animals, with brief notes of comparative medicine.
Collapse
Affiliation(s)
- Francesca Parisi
- Dipartimento di Scienze Veterinarie, Università di Pisa, Viale delle Piagge, 2, 56124, Pisa, Italy.
| | - Niccolò Fonti
- Dipartimento di Scienze Veterinarie, Università di Pisa, Viale delle Piagge, 2, 56124, Pisa, Italy
| | - Francesca Millanta
- Dipartimento di Scienze Veterinarie, Università di Pisa, Viale delle Piagge, 2, 56124, Pisa, Italy
| | - Giulia Freer
- Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Università di Pisa, Via Risorgimento, 36, 56126, Pisa, Italy
| | - Mauro Pistello
- Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Università di Pisa, Via Risorgimento, 36, 56126, Pisa, Italy
| | - Alessandro Poli
- Dipartimento di Scienze Veterinarie, Università di Pisa, Viale delle Piagge, 2, 56124, Pisa, Italy
| |
Collapse
|
3
|
AbuEed L, Makundi I, Miyake A, Kawasaki J, Minoura C, Koshida Y, Nishigaki K. Feline Foamy Virus Transmission in Tsushima Leopard Cats (Prionailurus bengalensis euptilurus) on Tsushima Island, Japan. Viruses 2023; 15:v15040835. [PMID: 37112816 PMCID: PMC10146696 DOI: 10.3390/v15040835] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2023] [Revised: 03/14/2023] [Accepted: 03/22/2023] [Indexed: 03/29/2023] Open
Abstract
Tsushima leopard cats (TLC; Prionailurus bengalensis euptilurus) only inhabit Tsushima Island, Nagasaki, Japan and are critically endangered and threatened by infectious diseases. The feline foamy virus (FFV) is widely endemic in domestic cats. Therefore, its transmission from domestic cats to TLCs may threaten the TLC population. Thus, this study aimed to assess the possibility that domestic cats could transmit FFV to TLCs. Eighty-nine TLC samples were screened, and FFV was identified in seven (7.86%). To assess the FFV infection status of domestic cats, 199 domestic cats were screened; 14.07% were infected. The phylogenetic analysis revealed that the FFV partial sequence from domestic cats and TLC sequences clustered in one clade, suggesting that the two populations share the same strain. The statistical data minimally supported the association between increased infection rate and sex (p = 0.28), indicating that FFV transmission is not sex dependent. In domestic cats, a significant difference was observed in FFV detection in feline immunodeficiency virus (p = 0.002) and gammaherpesvirus1 infection statuses (p = 0.0001) but not in feline leukemia virus infection status (p = 0.21). Monitoring FFV infection in domestic cats and TLC populations is highly recommended as part of TLC surveillance and management strategies.
Collapse
|
4
|
Sunpongsri S, Kovitvadhi A, Rattanasrisomporn J, Trisaksri V, Jensirisak N, Jaroensong T. Effectiveness and Adverse Events of Cyclophosphamide, Vincristine, and Prednisolone Chemotherapy in Feline Mediastinal Lymphoma Naturally Infected with Feline Leukemia Virus. Animals (Basel) 2022; 12:ani12070900. [PMID: 35405890 PMCID: PMC8997098 DOI: 10.3390/ani12070900] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2022] [Revised: 03/25/2022] [Accepted: 03/28/2022] [Indexed: 12/22/2022] Open
Abstract
Feline leukemia virus (FeLV) infection is considered a poor prognostic factor for feline lymphoma. This study investigated the prevalence of cats suffering from feline lymphoma with natural infection of the feline leukemia virus, as well as clinical signs, adverse events, and survival time after cyclophosphamide, vincristine and prednisolone (COP) chemotherapy. This retrospective study involved 92 cats diagnosed with mediastinal or mediastinal plus other anatomical sites of lymphoma and treated with COP chemotherapy. FeLV-antigen-positive was observed in all cats. Clinical signs and adverse events were observed after the 1st, 2nd, and 3rd inductions. Clinical signs improved after the 3rd induction of COP chemotherapy. The response rate was 96.74% (81.52% complete response, 15.22% partial response, and 3.26% no response). The overall median survival time was 338 days (range 62−1057 days). The overall response rate and median survival time of cats with feline lymphoma that were FeLV-antigen-positive and treated with COP chemotherapy were higher than from other studies. This study found that cats aged <4 years survived longer than those aged at least 4 years. Anemia (before COP), azotemia (after 2nd induction), and elevated alanine aminotransferase (after 1st induction) were associated with an increased chance of mortality.
Collapse
Affiliation(s)
- Supita Sunpongsri
- Kasetsart University Veterinary Teaching Hospital, Faculty of Veterinary Medicine, Kasetsart University, 50 Ngamwongwan Rd., Lat Yao, Chatuchak, Bangkok 10900, Thailand; (S.S.); (V.T.); (N.J.)
- Department of Companion Animal Clinical Sciences, Faculty of Veterinary Medicine, Kasetsart University, 50 Ngamwongwan Rd., Lat Yao, Chatuchak, Bangkok 10900, Thailand;
| | - Attawit Kovitvadhi
- Department of Physiology, Faculty of Veterinary Medicine, Kasetsart University, 50 Ngamwongwan Rd., Lat Yao, Chatuchak, Bangkok 10900, Thailand;
| | - Jatuporn Rattanasrisomporn
- Department of Companion Animal Clinical Sciences, Faculty of Veterinary Medicine, Kasetsart University, 50 Ngamwongwan Rd., Lat Yao, Chatuchak, Bangkok 10900, Thailand;
| | - Viphavee Trisaksri
- Kasetsart University Veterinary Teaching Hospital, Faculty of Veterinary Medicine, Kasetsart University, 50 Ngamwongwan Rd., Lat Yao, Chatuchak, Bangkok 10900, Thailand; (S.S.); (V.T.); (N.J.)
| | - Nichakorn Jensirisak
- Kasetsart University Veterinary Teaching Hospital, Faculty of Veterinary Medicine, Kasetsart University, 50 Ngamwongwan Rd., Lat Yao, Chatuchak, Bangkok 10900, Thailand; (S.S.); (V.T.); (N.J.)
| | - Tassanee Jaroensong
- Department of Companion Animal Clinical Sciences, Faculty of Veterinary Medicine, Kasetsart University, 50 Ngamwongwan Rd., Lat Yao, Chatuchak, Bangkok 10900, Thailand;
- Correspondence:
| |
Collapse
|
5
|
Krol L, Vernau W, Mutlow AG, Brady SM, Wack RF, Kubly S, Zwingenberger AL, Culp WTN, Palm C, Rebhun RB. Unusual splenic B-cell lymphoma in two related Sumatran tigers ( Panthera tigris sumatrae). J Am Vet Med Assoc 2021; 257:1288-1293. [PMID: 33269968 DOI: 10.2460/javma.257.12.1288] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
CASE DESCRIPTION A 14-year-old 120-kg (264-lb) sexually intact male Sumatran tiger (Panthera tigris sumatrae) and its 10-year-old 130-kg (286-lb) sexually intact male offspring were housed separately and evaluated independently after experiencing weeks of ongoing malaise, weight loss, and anorexia. CLINICAL FINDINGS Both animals were immobilized and anesthetized for physical examinations and diagnostic testing. Complete blood counts revealed leukopenia and anemia in both tigers. Splenomegaly was identified on abdominal ultrasonography. Cytologic examination and immunohistochemical staining of splenic samples confirmed intermediate to large B-cell lymphoma; no evidence of lymphoma in surrounding organs was noted. TREATMENT AND OUTCOME The sire was treated with lomustine and prednisolone. This tiger was euthanized 21 months after initiation of treatment because of chronic progressive renal disease. The male offspring was treated with l-asparaginase but did not respond to the treatment. A splenectomy was performed, and malaise and anorexia resolved. No further chemotherapy was administered, and the male offspring was instead maintained on a low dose of prednisolone. Thirty-two months after diagnosis, the male offspring was still considered to be in remission. CLINICAL RELEVANCE To our knowledge, this was the first known report of the diagnosis and management of a splenic B-cell lymphoma in a tiger. Both tigers achieved positive clinical responses and long-term survival by means of different treatment modalities. The finding of such an unusual neoplasm in a male tiger and its male offspring was noteworthy, raising the possibility of a genetic predisposition for this lymphoma type.
Collapse
|
6
|
Henrich M, Bauknecht A, Hecht W, Reinacher M. Lack of Bcl-2 expression in feline follicular lymphomas. J Vet Diagn Invest 2019; 31:809-817. [PMID: 31585524 DOI: 10.1177/1040638719877916] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023] Open
Abstract
Bcl-2, an anti-apoptotic protein, is commonly overexpressed in follicular lymphomas in humans. This is usually the result of a chromosomal translocation that transposes the Bcl-2 gene into the immunoglobulin gene locus. The immunohistochemical assessment of this overexpression can be used as a tool for the differentiation of follicular lymphoma and follicular hyperplasia. In cats, little information about the expression of Bcl-2 in follicular lymphoma exists. We investigated 18 follicular lymphomas histologically and immunohistochemically for the expression of Bcl-2, CD3, CD45R, and feline leukemia virus. Clonality was assessed by PCR for antigen receptor gene rearrangements. Although the histology resembled that of their human counterparts, diffuse expression of Bcl-2 within the follicles of the feline lymphomas, as seen in human cases, was not present. Only single cells within the follicles, comparable to the reactive controls, were positive for Bcl-2 expression. The mean survival time of 4.6 y confirmed the indolent character of the tumor. None of the clinical parameters assessed were statistically significant predictors of survival. Furthermore, a statistically significant difference in survival of animals with or without anti-neoplastic therapy was also not demonstrable.
Collapse
Affiliation(s)
- Manfred Henrich
- Institut fuer Veterinaer-Pathologie, Justus-Liebig-Universitaet Giessen, Giessen, Hessen, Germany
| | - Anna Bauknecht
- Institut fuer Veterinaer-Pathologie, Justus-Liebig-Universitaet Giessen, Giessen, Hessen, Germany
| | - Werner Hecht
- Institut fuer Veterinaer-Pathologie, Justus-Liebig-Universitaet Giessen, Giessen, Hessen, Germany
| | - Manfred Reinacher
- Institut fuer Veterinaer-Pathologie, Justus-Liebig-Universitaet Giessen, Giessen, Hessen, Germany
| |
Collapse
|
7
|
|
8
|
Paulin MV, Couronné L, Beguin J, Le Poder S, Delverdier M, Semin MO, Bruneau J, Cerf-Bensussan N, Malamut G, Cellier C, Benchekroun G, Tiret L, German AJ, Hermine O, Freiche V. Feline low-grade alimentary lymphoma: an emerging entity and a potential animal model for human disease. BMC Vet Res 2018; 14:306. [PMID: 30305106 PMCID: PMC6180644 DOI: 10.1186/s12917-018-1635-5] [Citation(s) in RCA: 40] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2018] [Accepted: 09/28/2018] [Indexed: 02/07/2023] Open
Abstract
BACKGROUND Low-grade alimentary lymphoma (LGAL) is characterised by the infiltration of neoplastic T-lymphocytes, typically in the small intestine. The incidence of LGAL has increased over the last ten years and it is now the most frequent digestive neoplasia in cats and comprises 60 to 75% of gastrointestinal lymphoma cases. Given that LGAL shares common clinical, paraclinical and ultrasonographic features with inflammatory bowel diseases, establishing a diagnosis is challenging. A review was designed to summarise current knowledge of the pathogenesis, diagnosis, prognosis and treatment of feline LGAL. Electronic searches of PubMed and Science Direct were carried out without date or language restrictions. RESULTS A total of 176 peer-reviewed documents were identified and most of which were published in the last twenty years. 130 studies were found from the veterinary literature and 46 from the human medicine literature. Heterogeneity of study designs and outcome measures made meta-analysis inappropriate. The pathophysiology of feline LGAL still needs to be elucidated, not least the putative roles of infectious agents, environmental factors as well as genetic events. The most common therapeutic strategy is combination treatment with prednisolone and chlorambucil, and prolonged remission can often be achieved. Developments in immunohistochemical analysis and clonality testing have improved the confidence of clinicians in obtaining a correct diagnosis between LGAL and IBD. The condition shares similarities with some diseases in humans, especially human indolent T-cell lymphoproliferative disorder of the gastrointestinal tract. CONCLUSIONS The pathophysiology of feline LGAL still needs to be elucidated and prospective studies as well as standardisation of therapeutic strategies are needed. A combination of conventional histopathology and immunohistochemistry remains the current gold-standard test, but clinicians should be cautious about reclassifying cats previously diagnosed with IBD to lymphoma on the basis of clonality testing. Importantly, feline LGAL could be considered to be a potential animal model for indolent digestive T-cell lymphoproliferative disorder, a rare condition in human medicine.
Collapse
Affiliation(s)
- Mathieu V Paulin
- Université Paris-Est, École Nationale Vétérinaire d'Alfort, 7 Avenue du Général de Gaulle, 94700, Maisons-Alfort, France
| | - Lucile Couronné
- Hematology Department, Hôpital Universitaire Necker - Enfants Malades, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.,Université Paris Descartes, Sorbonne Paris Cité, Paris, France.,INSERM UMR 1163, CNRS ERL 8254, Institut Imagine, Paris, France
| | - Jérémy Beguin
- Internal Medicine Department, Université Paris-Est, École Nationale Vétérinaire d'Alfort, 7 Avenue du Général de Gaulle, 94700, Maisons-Alfort, France
| | - Sophie Le Poder
- UMR 1161 Virologie, INRA-ENVA-ANSES, Université Paris-Est, École Nationale Vétérinaire d'Alfort, Maisons-Alfort, France
| | - Maxence Delverdier
- Anatomical Pathology Department, Université de Toulouse, École Nationale Vétérinaire de Toulouse, 23 Chemin des Capelles, 31076, Toulouse Cedex, France
| | - Marie-Odile Semin
- Anatomical Pathology Department, Université de Toulouse, École Nationale Vétérinaire de Toulouse, 23 Chemin des Capelles, 31076, Toulouse Cedex, France
| | - Julie Bruneau
- Pathology Department, Hôpital Universitaire Necker - Enfants Malades, Assistance Publique - Hôpitaux de Paris (APHP), Université Paris Descartes, Sorbonne Paris Cité, Paris, France.,INSERM 1163, Institut Imagine, Site Hôpital Universitaire Necker - Enfants Malades, Paris, France
| | - Nadine Cerf-Bensussan
- Université Paris Descartes, Sorbonne Paris Cité, Paris, France.,UMR 1163, Laboratory of Intestinal Immunity, INSERM, Paris, France
| | - Georgia Malamut
- Gastroenterology Department, Hôpital Européen Georges Pompidou, Assistance Publique - Hôpitaux de Paris (APHP), Université Paris Descartes, Sorbonne Paris Cité, Paris, France.,INSERM UMR 1163, Institut Imagine, Paris, France
| | - Christophe Cellier
- Gastroenterology Department, Hôpital Européen Georges Pompidou, Assistance Publique - Hôpitaux de Paris (APHP), Université Paris Descartes, Sorbonne Paris Cité, Paris, France.,INSERM UMR 1163, Institut Imagine, Paris, France
| | - Ghita Benchekroun
- Internal Medicine Department, Université Paris-Est, École Nationale Vétérinaire d'Alfort, 7 Avenue du Général de Gaulle, 94700, Maisons-Alfort, France
| | - Laurent Tiret
- Inserm U955-E10 BNMS, IMRB, Université Paris-Est, École Nationale Vétérinaire d'Alfort, 94000, Maisons-Alfort, France
| | - Alexander J German
- Institute of Ageing and Chronic Disease, University of Liverpool, Leahurst Campus, Chester High Road, Neston, CH64 7TE, UK
| | - Olivier Hermine
- Hematology Department, Hôpital Universitaire Necker - Enfants Malades, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.,Université Paris Descartes, Sorbonne Paris Cité, Paris, France.,INSERM UMR 1163, CNRS ERL 8254, Institut Imagine, Paris, France
| | - Valérie Freiche
- Internal Medicine Department, Université Paris-Est, École Nationale Vétérinaire d'Alfort, 7 Avenue du Général de Gaulle, 94700, Maisons-Alfort, France.
| |
Collapse
|
9
|
Kaye S, Wang W, Miller C, McLuckie A, Beatty JA, Grant CK, VandeWoude S, Bielefeldt-Ohmann H. Role of Feline Immunodeficiency Virus in Lymphomagenesis--Going Alone or Colluding? ILAR J 2017; 57:24-33. [PMID: 27034392 DOI: 10.1093/ilar/ilv047] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
Feline immunodeficiency virus (FIV) is a naturally occurring lentivirus of domestic and nondomestic feline species. Infection in domestic cats leads to immune dysfunction via mechanisms similar to those caused by human immunodeficiency virus (HIV) and, as such, is a valuable natural animal model for acquired immunodeficiency syndrome (AIDS) in humans. An association between FIV and an increased incidence of neoplasia has long been recognized, with frequencies of up to 20% in FIV-positive cats recorded in some studies. This is similar to the rate of neoplasia seen in HIV-positive individuals, and in both species neoplasia typically requires several years to arise. The most frequently reported type of neoplasia associated with FIV infection is lymphoma. Here we review the possible mechanisms involved in FIV lymphomagenesis, including the possible involvement of coinfections, notably those with gamma-herpesviruses.
Collapse
Affiliation(s)
- Sarah Kaye
- Sarah Kaye, BVSc, is a small animal clinician with the Animal Welfare League Qld Inc. in The Gold Coast, Queensland, Australia. Wenqi Wang, BVSc, PhD, is a postdoctoral fellow affiliated with the School of Veterinary Science at University of Queensland at Gatton in Australia. Craig Miller, DVM, is a postdoctoral fellow in the Department of Microbiology, Immunology & Pathology at Colorado State University in FortCollins, Colorado. Alicia McLuckie, BVSc, is a PhD candidate in the Faculty of Veterinary Science at the University of Sydney in NSW, Australia, Julia A. Beatty, BSc, BVetMed, PhD, FANZCVs (feline med), is a professor in the Faculty of Veterinary Science at the University of Sydney in NSW, Australia. Chris K. Grant, PhD, DSc, is founder and CEO of Custom Monoclonals International Corp. in West Sacramento, California. Sue VandeWoude, DVM, MS, DACLAM, is a professor in the Department of Microbiology, Immunology & Pathology at Colorado State University and Associate Dean for Research in the College of Veterinary & Biomedical Sciences at Colorado State University in Fort Collins, Colorado. Helle Bielefeldt-Ohmann, DVM, PhD, is a senior lecturer in the School of Veterinary Science at the University of Queensland at Gatton, an affiliate senior lecturer in the School of Chemistry & Molecular Biosciences at the University of Queensland at St. Lucia, and an investigator at the Australian Infectious Diseases Research Centre at the University of Queensland in St. Lucia, Australia
| | - Wenqi Wang
- Sarah Kaye, BVSc, is a small animal clinician with the Animal Welfare League Qld Inc. in The Gold Coast, Queensland, Australia. Wenqi Wang, BVSc, PhD, is a postdoctoral fellow affiliated with the School of Veterinary Science at University of Queensland at Gatton in Australia. Craig Miller, DVM, is a postdoctoral fellow in the Department of Microbiology, Immunology & Pathology at Colorado State University in FortCollins, Colorado. Alicia McLuckie, BVSc, is a PhD candidate in the Faculty of Veterinary Science at the University of Sydney in NSW, Australia, Julia A. Beatty, BSc, BVetMed, PhD, FANZCVs (feline med), is a professor in the Faculty of Veterinary Science at the University of Sydney in NSW, Australia. Chris K. Grant, PhD, DSc, is founder and CEO of Custom Monoclonals International Corp. in West Sacramento, California. Sue VandeWoude, DVM, MS, DACLAM, is a professor in the Department of Microbiology, Immunology & Pathology at Colorado State University and Associate Dean for Research in the College of Veterinary & Biomedical Sciences at Colorado State University in Fort Collins, Colorado. Helle Bielefeldt-Ohmann, DVM, PhD, is a senior lecturer in the School of Veterinary Science at the University of Queensland at Gatton, an affiliate senior lecturer in the School of Chemistry & Molecular Biosciences at the University of Queensland at St. Lucia, and an investigator at the Australian Infectious Diseases Research Centre at the University of Queensland in St. Lucia, Australia
| | - Craig Miller
- Sarah Kaye, BVSc, is a small animal clinician with the Animal Welfare League Qld Inc. in The Gold Coast, Queensland, Australia. Wenqi Wang, BVSc, PhD, is a postdoctoral fellow affiliated with the School of Veterinary Science at University of Queensland at Gatton in Australia. Craig Miller, DVM, is a postdoctoral fellow in the Department of Microbiology, Immunology & Pathology at Colorado State University in FortCollins, Colorado. Alicia McLuckie, BVSc, is a PhD candidate in the Faculty of Veterinary Science at the University of Sydney in NSW, Australia, Julia A. Beatty, BSc, BVetMed, PhD, FANZCVs (feline med), is a professor in the Faculty of Veterinary Science at the University of Sydney in NSW, Australia. Chris K. Grant, PhD, DSc, is founder and CEO of Custom Monoclonals International Corp. in West Sacramento, California. Sue VandeWoude, DVM, MS, DACLAM, is a professor in the Department of Microbiology, Immunology & Pathology at Colorado State University and Associate Dean for Research in the College of Veterinary & Biomedical Sciences at Colorado State University in Fort Collins, Colorado. Helle Bielefeldt-Ohmann, DVM, PhD, is a senior lecturer in the School of Veterinary Science at the University of Queensland at Gatton, an affiliate senior lecturer in the School of Chemistry & Molecular Biosciences at the University of Queensland at St. Lucia, and an investigator at the Australian Infectious Diseases Research Centre at the University of Queensland in St. Lucia, Australia
| | - Alicia McLuckie
- Sarah Kaye, BVSc, is a small animal clinician with the Animal Welfare League Qld Inc. in The Gold Coast, Queensland, Australia. Wenqi Wang, BVSc, PhD, is a postdoctoral fellow affiliated with the School of Veterinary Science at University of Queensland at Gatton in Australia. Craig Miller, DVM, is a postdoctoral fellow in the Department of Microbiology, Immunology & Pathology at Colorado State University in FortCollins, Colorado. Alicia McLuckie, BVSc, is a PhD candidate in the Faculty of Veterinary Science at the University of Sydney in NSW, Australia, Julia A. Beatty, BSc, BVetMed, PhD, FANZCVs (feline med), is a professor in the Faculty of Veterinary Science at the University of Sydney in NSW, Australia. Chris K. Grant, PhD, DSc, is founder and CEO of Custom Monoclonals International Corp. in West Sacramento, California. Sue VandeWoude, DVM, MS, DACLAM, is a professor in the Department of Microbiology, Immunology & Pathology at Colorado State University and Associate Dean for Research in the College of Veterinary & Biomedical Sciences at Colorado State University in Fort Collins, Colorado. Helle Bielefeldt-Ohmann, DVM, PhD, is a senior lecturer in the School of Veterinary Science at the University of Queensland at Gatton, an affiliate senior lecturer in the School of Chemistry & Molecular Biosciences at the University of Queensland at St. Lucia, and an investigator at the Australian Infectious Diseases Research Centre at the University of Queensland in St. Lucia, Australia
| | - Julia A Beatty
- Sarah Kaye, BVSc, is a small animal clinician with the Animal Welfare League Qld Inc. in The Gold Coast, Queensland, Australia. Wenqi Wang, BVSc, PhD, is a postdoctoral fellow affiliated with the School of Veterinary Science at University of Queensland at Gatton in Australia. Craig Miller, DVM, is a postdoctoral fellow in the Department of Microbiology, Immunology & Pathology at Colorado State University in FortCollins, Colorado. Alicia McLuckie, BVSc, is a PhD candidate in the Faculty of Veterinary Science at the University of Sydney in NSW, Australia, Julia A. Beatty, BSc, BVetMed, PhD, FANZCVs (feline med), is a professor in the Faculty of Veterinary Science at the University of Sydney in NSW, Australia. Chris K. Grant, PhD, DSc, is founder and CEO of Custom Monoclonals International Corp. in West Sacramento, California. Sue VandeWoude, DVM, MS, DACLAM, is a professor in the Department of Microbiology, Immunology & Pathology at Colorado State University and Associate Dean for Research in the College of Veterinary & Biomedical Sciences at Colorado State University in Fort Collins, Colorado. Helle Bielefeldt-Ohmann, DVM, PhD, is a senior lecturer in the School of Veterinary Science at the University of Queensland at Gatton, an affiliate senior lecturer in the School of Chemistry & Molecular Biosciences at the University of Queensland at St. Lucia, and an investigator at the Australian Infectious Diseases Research Centre at the University of Queensland in St. Lucia, Australia
| | - Chris K Grant
- Sarah Kaye, BVSc, is a small animal clinician with the Animal Welfare League Qld Inc. in The Gold Coast, Queensland, Australia. Wenqi Wang, BVSc, PhD, is a postdoctoral fellow affiliated with the School of Veterinary Science at University of Queensland at Gatton in Australia. Craig Miller, DVM, is a postdoctoral fellow in the Department of Microbiology, Immunology & Pathology at Colorado State University in FortCollins, Colorado. Alicia McLuckie, BVSc, is a PhD candidate in the Faculty of Veterinary Science at the University of Sydney in NSW, Australia, Julia A. Beatty, BSc, BVetMed, PhD, FANZCVs (feline med), is a professor in the Faculty of Veterinary Science at the University of Sydney in NSW, Australia. Chris K. Grant, PhD, DSc, is founder and CEO of Custom Monoclonals International Corp. in West Sacramento, California. Sue VandeWoude, DVM, MS, DACLAM, is a professor in the Department of Microbiology, Immunology & Pathology at Colorado State University and Associate Dean for Research in the College of Veterinary & Biomedical Sciences at Colorado State University in Fort Collins, Colorado. Helle Bielefeldt-Ohmann, DVM, PhD, is a senior lecturer in the School of Veterinary Science at the University of Queensland at Gatton, an affiliate senior lecturer in the School of Chemistry & Molecular Biosciences at the University of Queensland at St. Lucia, and an investigator at the Australian Infectious Diseases Research Centre at the University of Queensland in St. Lucia, Australia
| | - Sue VandeWoude
- Sarah Kaye, BVSc, is a small animal clinician with the Animal Welfare League Qld Inc. in The Gold Coast, Queensland, Australia. Wenqi Wang, BVSc, PhD, is a postdoctoral fellow affiliated with the School of Veterinary Science at University of Queensland at Gatton in Australia. Craig Miller, DVM, is a postdoctoral fellow in the Department of Microbiology, Immunology & Pathology at Colorado State University in FortCollins, Colorado. Alicia McLuckie, BVSc, is a PhD candidate in the Faculty of Veterinary Science at the University of Sydney in NSW, Australia, Julia A. Beatty, BSc, BVetMed, PhD, FANZCVs (feline med), is a professor in the Faculty of Veterinary Science at the University of Sydney in NSW, Australia. Chris K. Grant, PhD, DSc, is founder and CEO of Custom Monoclonals International Corp. in West Sacramento, California. Sue VandeWoude, DVM, MS, DACLAM, is a professor in the Department of Microbiology, Immunology & Pathology at Colorado State University and Associate Dean for Research in the College of Veterinary & Biomedical Sciences at Colorado State University in Fort Collins, Colorado. Helle Bielefeldt-Ohmann, DVM, PhD, is a senior lecturer in the School of Veterinary Science at the University of Queensland at Gatton, an affiliate senior lecturer in the School of Chemistry & Molecular Biosciences at the University of Queensland at St. Lucia, and an investigator at the Australian Infectious Diseases Research Centre at the University of Queensland in St. Lucia, Australia
| | - Helle Bielefeldt-Ohmann
- Sarah Kaye, BVSc, is a small animal clinician with the Animal Welfare League Qld Inc. in The Gold Coast, Queensland, Australia. Wenqi Wang, BVSc, PhD, is a postdoctoral fellow affiliated with the School of Veterinary Science at University of Queensland at Gatton in Australia. Craig Miller, DVM, is a postdoctoral fellow in the Department of Microbiology, Immunology & Pathology at Colorado State University in FortCollins, Colorado. Alicia McLuckie, BVSc, is a PhD candidate in the Faculty of Veterinary Science at the University of Sydney in NSW, Australia, Julia A. Beatty, BSc, BVetMed, PhD, FANZCVs (feline med), is a professor in the Faculty of Veterinary Science at the University of Sydney in NSW, Australia. Chris K. Grant, PhD, DSc, is founder and CEO of Custom Monoclonals International Corp. in West Sacramento, California. Sue VandeWoude, DVM, MS, DACLAM, is a professor in the Department of Microbiology, Immunology & Pathology at Colorado State University and Associate Dean for Research in the College of Veterinary & Biomedical Sciences at Colorado State University in Fort Collins, Colorado. Helle Bielefeldt-Ohmann, DVM, PhD, is a senior lecturer in the School of Veterinary Science at the University of Queensland at Gatton, an affiliate senior lecturer in the School of Chemistry & Molecular Biosciences at the University of Queensland at St. Lucia, and an investigator at the Australian Infectious Diseases Research Centre at the University of Queensland in St. Lucia, Australia
| |
Collapse
|
10
|
Swiss Feline Cancer Registry 1965–2008: the Influence of Sex, Breed and Age on Tumour Types and Tumour Locations. J Comp Pathol 2016; 154:195-210. [DOI: 10.1016/j.jcpa.2016.01.008] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2015] [Revised: 01/16/2016] [Accepted: 01/22/2016] [Indexed: 11/23/2022]
|
11
|
Zambelli A. Feline Cancer Prevalence in South Africa (1998 – 2005): Contrasts with the Rest of the World. ACTA ACUST UNITED AC 2015. [DOI: 10.6000/1927-5129.2015.11.53] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]
|
12
|
Beatty J. Viral causes of feline lymphoma: Retroviruses and beyond. Vet J 2014; 201:174-80. [DOI: 10.1016/j.tvjl.2014.05.026] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2013] [Revised: 05/11/2014] [Accepted: 05/17/2014] [Indexed: 11/30/2022]
|
13
|
Fabrizio F, Calam AE, Dobson JM, Middleton SA, Murphy S, Taylor SS, Schwartz A, Stell AJ. Feline mediastinal lymphoma: a retrospective study of signalment, retroviral status, response to chemotherapy and prognostic indicators. J Feline Med Surg 2013; 16:637-44. [DOI: 10.1177/1098612x13516621] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Historically, feline mediastinal lymphoma has been associated with young age, positive feline leukaemia virus (FeLV) status, Siamese breed and short survival times. Recent studies following widespread FeLV vaccination in the UK are lacking. The aim of this retrospective multi-institutional study was to re-evaluate the signalment, retroviral status, response to chemotherapy, survival and prognostic indicators in feline mediastinal lymphoma cases in the post-vaccination era. Records of cats with clinical signs associated with a mediastinal mass and cytologically/histologically confirmed lymphoma were reviewed from five UK referral centres (1998–2010). Treatment response, survival and prognostic indicators were assessed in treated cats with follow-up data. Fifty-five cases were reviewed. The median age was 3 years (range, 0.5–12 years); 12 cats (21.8%) were Siamese; and the male to female ratio was 3.2:1.0. Five cats were FeLV-positive and two were feline immunodeficiency-positive. Chemotherapy response and survival was evaluated in 38 cats. Overall response was 94.7%; complete (CR) and partial response (PR) rates did not differ significantly between protocols: COP (cyclophosphamide, vincristine, prednisone) (n = 26, CR 61.5%, PR 34.0%); Madison–Wisconsin (MW) (n = 12, CR 66.7%, PR 25.0%). Overall median survival was 373 days (range, 20–2015 days) (COP 484 days [range, 20–980 days]; MW 211 days [range, 24–2015 days] [ P = 0.892]). Cats achieving CR survived longer (980 days vs 42 days for PR; P = 0.032). Age, breed, sex, location (mediastinal vs mediastinal plus other sites), retroviral status and glucocorticoid pretreatment did not affect response or survival. Feline mediastinal lymphoma cases frequently responded to chemotherapy with durable survival times, particularly in cats achieving CR. The prevalence of FeLV-antigenaemic cats was low; males and young Siamese cats appeared to be over-represented.
Collapse
|
14
|
Gustafson TL, Villamil A, Taylor BE, Flory A. A retrospective study of feline gastric lymphoma in 16 chemotherapy-treated cats. J Am Anim Hosp Assoc 2013; 50:46-52. [PMID: 24216491 DOI: 10.5326/jaaha-ms-5989] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
The purposes of this study were to describe cases of feline gastric lymphoma with regards to signalment, clinical presentation, laboratory and ancillary study findings, response to therapy, and outcomes and to identify prognostic variables. Sixteen cats with stage I and II gastric lymphoma treated with chemotherapy were included in this study. Seventy-five percent of cats experienced remission. Overall, first remission duration was 108 days. Response to treatment was prognostic as in other types of feline lymphoma. Cats with a complete remission (CR) had longer survival times compared with cats with a partial remission (PR). Sex and treatment with a rescue protocol were found to be prognostic with castrated males having longer survivals than spayed females. Cats that received rescue chemotherapy had shorter first remission durations than those that did not. Prior treatment with steroids and stage were not found to be significant prognostic variables. This study characterizes gastric lymphoma treated with chemotherapy in cats. Further studies are needed to determine the comparative efficacy of surgical and chemotherapeutic treatments for feline gastric lymphoma.
Collapse
|
15
|
Amati M, Venco L, Roccabianca P, Santagostino SF, Bertazzolo W. Pericardial lymphoma in seven cats. J Feline Med Surg 2013; 16:507-12. [DOI: 10.1177/1098612x13506199] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
A presumed primary pericardial lymphoma was diagnosed in seven cats. Clinical findings at presentation included poor body condition, dehydration and dyspnoea. Thoracic diagnostic imaging was performed in six cases and revealed pleural effusion and a diffuse thickening of the pericardium. A cytological diagnosis of lymphoma was obtained in six cases; in four cases the diagnosis was confirmed at necropsy. Immunophenotyping was performed in six cases: three cases were classified as T-cell and three as B-cell lymphoma. Four cats did not receive any treatment. One cat received only prednisone and two cats received chemotherapy. Six cats lived 7–11 days, except for one cat that received a multi-drug chemotherapy protocol and was still alive at the time of writing (750 days after diagnosis). Primary pericardial lymphoma is a rare extranodal feline lymphoma that has never been described previously.
Collapse
Affiliation(s)
- Maria Amati
- Veterinary Hospital of the City of Pavia, Pavia, Italy
| | - Luigi Venco
- Veterinary Hospital of the City of Pavia, Pavia, Italy
| | - Paola Roccabianca
- Department of Veterinary Sciences and Public Health (DIVET), University of Milan, Milan, Italy
| | | | | |
Collapse
|
16
|
Waite AHK, Jackson K, Gregor TP, Krick EL. Lymphoma in cats treated with a weekly cyclophosphamide-, vincristine-, and prednisone-based protocol: 114 cases (1998–2008). J Am Vet Med Assoc 2013; 242:1104-9. [DOI: 10.2460/javma.242.8.1104] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
17
|
Magden E, Miller C, MacMillan M, Bielefeldt-Ohmann H, Avery A, Quackenbush SL, Vandewoude S. Acute virulent infection with feline immunodeficiency virus (FIV) results in lymphomagenesis via an indirect mechanism. Virology 2013; 436:284-94. [PMID: 23290868 DOI: 10.1016/j.virol.2012.12.003] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2012] [Revised: 10/30/2012] [Accepted: 12/04/2012] [Indexed: 10/27/2022]
Abstract
Four cats (24%) experimentally infected with FIV unexpectedly developed neoplastic changes within four months of inoculation. While FIV has previously been associated with neoplasia, the rapidity and high attack rate seen here is highly unusual. PCR for antigen receptor rearrangements (PARR) detected clonally rearranged T cells in two animals diagnosed with B cell follicular lymphoma by classical means. All cats were negative for feline leukemia virus; gamma-herpesvirus DNA was not amplified using degenerate primers. FIV proviral load in neoplastic tissue was two orders of magnitude lower than in the periphery, lower in neoplastic vs non-neoplastic lymph node, and clonal integration was not detected. We hypothesize that neoplasia was secondary to FIV immune dysregulation, and show that PARR can augment our capacity to phenotype these tumors and distinguish follicular hyperplasia from lymphoma. Age of exposure and relative virulence of the inoculum likely contributed to this unusual presentation of FIV infection.
Collapse
|
18
|
Hematopoietic Tumors. WITHROW AND MACEWEN'S SMALL ANIMAL CLINICAL ONCOLOGY 2013. [PMCID: PMC7161412 DOI: 10.1016/b978-1-4377-2362-5.00032-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
19
|
Abstract
Feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV) are retroviruses with global impact on the health of domestic cats. The two viruses differ in their potential to cause disease. FeLV is more pathogenic, and was long considered to be responsible for more clinical syndromes than any other agent in cats. FeLV can cause tumors (mainly lymphoma), bone marrow suppression syndromes (mainly anemia), and lead to secondary infectious diseases caused by suppressive effects of the virus on bone marrow and the immune system. Today, FeLV is less commonly diagnosed than in the previous 20 years; prevalence has been decreasing in most countries. However, FeLV importance may be underestimated as it has been shown that regressively infected cats (that are negative in routinely used FeLV tests) also can develop clinical signs. FIV can cause an acquired immunodeficiency syndrome that increases the risk of opportunistic infections, neurological diseases, and tumors. In most naturally infected cats, however, FIV itself does not cause severe clinical signs, and FIV-infected cats may live many years without any health problems. This article provides a review of clinical syndromes in progressively and regressively FeLV-infected cats as well as in FIV-infected cats.
Collapse
Affiliation(s)
- Katrin Hartmann
- Medizinische Kleintierklinik, LMU University of Munich, Germany, Veterinaerstrasse 13, 80539 Munich, Germany.
| |
Collapse
|
20
|
Teske E, van Lankveld AJ, Rutteman GR. Intraperitoneal antineoplastic drug delivery: experience with a cyclophosphamide, vincristine and prednisolone protocol in cats with malignant lymphoma. Vet Comp Oncol 2012; 12:37-46. [DOI: 10.1111/j.1476-5829.2012.00329.x] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- E. Teske
- Department of Clinical Sciences of Companion Animals, Veterinary Faculty; Utrecht University; Utrecht The Netherlands
| | - A. J. van Lankveld
- Department of Clinical Sciences of Companion Animals, Veterinary Faculty; Utrecht University; Utrecht The Netherlands
| | - G. R. Rutteman
- Department of Clinical Sciences of Companion Animals, Veterinary Faculty; Utrecht University; Utrecht The Netherlands
| |
Collapse
|
21
|
Abstract
Practical relevance Alimentary lymphoma (AL) occurs commonly in cats and exists as distinct subtypes that differ in their clinical course, response to treatment and prognosis. Accurate diagnosis is important to guide appropriate treatment. Clinical challenges Differentiation of low-grade alimentary lymphoma from lymphoplasmacytic enteritis can be challenging, especially where endoscopic intestinal biopsies, which sample only the mucosa and submucosa, are used. The major differentials for intermediate- and high-grade alimentary lymphoma are other neoplastic and non-neoplastic intestinal mass lesions. The diagnosis of large granular lymphocyte lymphoma requires vigilance as it may be missed with routine diagnostics. Patient group AL affects predominantly middle- to old-aged domestic crossbred cats (median age 10–13 years). Evidence base The evidence supporting this review is grade II, III and IV, derived from prospective studies, retrospective case series, reviews, extrapolation from other species, pathophysiological justification and the combined clinical experience of those working in the field.
Collapse
Affiliation(s)
- Vanessa Barrs
- Valentine Charlton Cat Centre, Faculty of Veterinary Science, University of Sydney, Sydney NSW 2006, Australia
| | - Julia Beatty
- Valentine Charlton Cat Centre, Faculty of Veterinary Science, University of Sydney, Sydney NSW 2006, Australia
| |
Collapse
|
22
|
Beatty JA, Tasker S, Jarrett O, Lam A, Gibson S, Noe-Nordberg A, Phillips A, Fawcett A, Barrs VR. Markers of Feline Leukaemia Virus Infection or Exposure in Cats from a Region of Low Seroprevalence. J Feline Med Surg 2011; 13:927-33. [PMID: 21880527 DOI: 10.1016/j.jfms.2011.07.011] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2011] [Revised: 07/11/2011] [Accepted: 07/16/2011] [Indexed: 11/18/2022]
Abstract
Molecular techniques have demonstrated that cats may harbour feline leukaemia virus (FeLV) provirus in the absence of antigenaemia. Using quantitative real-time polymerase chain reaction (qPCR), p27 enzyme-linked immunosorbent assay (ELISA), anti-feline oncornavirus-associated cell-membrane-antigen (FOCMA) antibody testing and virus isolation (VI) we investigated three groups of cats. Among cats with cytopenias or lymphoma, 2/75 were transiently positive for provirus and anti-FOCMA antibodies were the only evidence of exposure in another. In 169 young, healthy cats, all tests were negative. In contrast, 3/4 cats from a closed household where FeLV was confirmed by isolation, had evidence of infection. Our results support a role for factors other than FeLV in the pathogenesis of cytopenias and lymphoma. There was no evidence of exposure in young cats. In regions of low prevalence, where the positive predictive value of antigen testing is low, qPCR may assist with diagnosis.
Collapse
Affiliation(s)
- Julia A Beatty
- Valentine Charlton Cat Centre, Faculty of Veterinary Science, The University of Sydney, NSW 2006, Australia.
| | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Hartmann K. Clinical aspects of feline immunodeficiency and feline leukemia virus infection. Vet Immunol Immunopathol 2011; 143:190-201. [PMID: 21807418 PMCID: PMC7132395 DOI: 10.1016/j.vetimm.2011.06.003] [Citation(s) in RCA: 97] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV) are retroviruses with a global impact on the health of domestic cats. The two viruses differ in their potential to cause disease. FIV can cause an acquired immunodeficiency syndrome that increases the risk of developing opportunistic infections, neurological diseases, and tumors. In most naturally infected cats, however, FIV itself does not cause severe clinical signs, and FIV-infected cats may live many years without any health problems. FeLV is more pathogenic, and was long considered to be responsible for more clinical syndromes than any other agent in cats. FeLV can cause tumors (mainly lymphoma), bone marrow suppression syndromes (mainly anemia) and lead to secondary infectious diseases caused by suppressive effects of the virus on bone marrow and the immune system. Today, FeLV is less important as a deadly infectious agent as in the last 20 years prevalence has been decreasing in most countries.
Collapse
Affiliation(s)
- Katrin Hartmann
- Clinic of Small Animal Medicine, LMU University of Munich, Veterinaerstrasse 13, 80539 Munich, Germany.
| |
Collapse
|
24
|
Magden E, Quackenbush SL, VandeWoude S. FIV associated neoplasms--a mini-review. Vet Immunol Immunopathol 2011; 143:227-34. [PMID: 21722968 DOI: 10.1016/j.vetimm.2011.06.016] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
Retroviral induced neoplasms have been key to understanding oncogenesis and are important etiologic agents associated with cancer formation. Cats infected with feline immunodeficiency virus (FIV), the feline analogue to human immunodeficiency virus (HIV), are reported to be at increased incidence of neoplasia. This review highlights reported risk factors and tumor cell phenotypes associated with neoplasias arising in FIV-infected animals, differences in oncogenic disease in natural versus experimental FIV infections, and similarities between FIV- and HIV-related malignancies. The most common type of FIV-associated neoplasm reported in the literature is lymphoma, specifically of B-cell origin, with experimentally infected cats developing neoplastic lesions at an earlier age than their naturally infected cohorts. The mechanism of FIV-induced lymphoma has not been completely ascertained, though the majority of published studies addressing this issue suggest oncogenesis arises via indirect mechanisms. HIV-infected individuals have increased risk of neoplasia, specifically B cell lymphoma, in comparison with uninfected individuals. Additional similarities between FIV- and HIV-associated neoplasms include the presence of extranodal lymphoma, a synergism with other oncogenic viruses, and an apparent indirect mechanism of induced oncogenesis. This literature supports study of FIV-associated neoplasms to further characterize this lentiviral-neoplasia association for the benefit of both human and animal disease, and to advance our general knowledge of mechanisms for viral-induced oncogenesis.
Collapse
Affiliation(s)
- Elizabeth Magden
- Colorado State University, Department of Microbiology, Immunology, and Pathology, 1619 Campus Delivery, Fort Collins, CO 80523, USA
| | | | | |
Collapse
|
25
|
Taylor SS, Goodfellow MR, Browne WJ, Walding B, Murphy S, Tzannes S, Gerou-Ferriani M, Schwartz A, Dobson JM. Feline extranodal lymphoma: response to chemotherapy and survival in 110 cats. J Small Anim Pract 2010; 50:584-92. [PMID: 19891724 DOI: 10.1111/j.1748-5827.2009.00813.x] [Citation(s) in RCA: 74] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
OBJECTIVE To determine response to treatment, survival and prognostic factors for feline extranodal lymphoma in the UK. METHODS Records of cats diagnosed with lymphoma of extranodal sites at seven referral centres were reviewed and information on signalment, tumour location, prior treatment and chemotherapy protocol recorded. Factors influencing response to treatment and survival were assessed. RESULTS One hundred and forty-nine cases met inclusion criteria. Sixty-nine cats had nasal lymphoma, 35 renal, 15 central nervous system, 11 laryngeal and 19 miscellaneous locations. Sixty-six cats received cyclophosphamide, vincristine, prednisolone, 25 Wisconsin-Madison doxorubicin-containing multi-agent protocol, 10 prednisolone alone and nine other combinations. The response rate for the 110 treated cats was 85.5 per cent. Of cyclophosphamide, vincristine, prednisolone treated cats 72.7 per cent achieved complete remission, median survival 239 days. Sixty-four per cent of Wisconsin-Madison treated cats achieved complete remission, median survival 563 days. Cats with nasal lymphoma achieving complete remission had the longest survival (749 days) and cats with central nervous system lymphoma the shortest (70 days). If complete remission was achieved, prior treatment with corticosteroids significantly reduced survival time. CLINICAL SIGNIFICANCE Cats with extranodal lymphoma respond to chemotherapy and achieve survival times comparable to other locations. Corticosteroid pretreatment reduced survival time in cats achieving complete remission.
Collapse
Affiliation(s)
- S S Taylor
- The Feline Centre, Department of Clinical Veterinary Science, Division of Companion Animals, University of Bristol, Langford, Bristol BS405DU
| | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Abstract
Alimentary lymphoma is one of the most commonly diagnosed neoplasms of the cat. The incidence of this disease has increased significantly over the past 15 years during the post-feline leukemia era. Despite the common prevalence of this disease, appropriate diagnosis and treatment can be challenging. There are two main forms of feline alimentary lymphoma: the small-cell (lymphocytic, well-differentiated, low-grade) lymphoma variety and the large-cell (lymphoblastic, high-grade) lymphoma variety. These two diseases are related; however, each presents its own diagnostic and therapeutic challenges. Additionally, it can be difficult to differentiate these malignancies from other nonneoplastic diseases such as inflammatory bowel disease and other chronic inflammatory conditions of the gastrointestinal tract. The purpose of this article is to tackle the challenges of this allusive disease with a step-by-step approach to diagnosis, staging, and therapy.
Collapse
Affiliation(s)
- Heather M Wilson
- Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Texas A&M University, College Station, TX 77843, USA.
| |
Collapse
|
27
|
Seo KW, Choi US, Bae BK, Park MS, Hwang CY, Kim DY, Youn HY. Mediastinal lymphoma in a young Turkish Angora cat. J Vet Sci 2006; 7:199-201. [PMID: 16645348 PMCID: PMC3242115 DOI: 10.4142/jvs.2006.7.2.199] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/05/2022] Open
Abstract
An 8-month old intact male Turkish Angora cat was referred to the Veterinary Medical Teaching Hospital (VMTH), Seoul National University, for an evaluation of anorexia and severe dyspnea. The thoracic radiographs revealed significant pleural effusion. A cytology evaluation of the pleural fluid strongly suggested a lymphoma containing variable sized lymphocytes with frequent mitotic figures and prominent nucleoli. The feline leukemia virus and feline immunodeficiency virus tests were negative. The cat was euthanized at his owner's request and a necropsy was performed. A mass was detected on the mediastinum and lung lobes. A histopathology evaluation confirmed the mass to be a lymphoma. Immunohistochemistry revealed the mass to be CD3 positive. In conclusion, the cat was diagnosed as a T-cell mediastinal lymphoma.
Collapse
Affiliation(s)
- Kyoung Won Seo
- Department of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University, Seoul 151-742, Korea
| | | | | | | | | | | | | |
Collapse
|
28
|
Waly NE, Gruffydd-Jones TJ, Stokes CR, Day MJ. Immunohistochemical Diagnosis of Alimentary Lymphomas and Severe Intestinal Inflammation in Cats. J Comp Pathol 2005; 133:253-60. [PMID: 16213517 DOI: 10.1016/j.jcpa.2005.05.004] [Citation(s) in RCA: 60] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2004] [Accepted: 05/23/2005] [Indexed: 11/23/2022]
Abstract
Intestinal tissue samples were examined from 32 cats in which a histopathological diagnosis of alimentary lymphoma or multicentric lymphoma affecting the gastrointestinal tract had been made. These samples were re-evaluated histopathologically and serial sections were examined immunohistochemically with antisera specific for the lymphoid markers CD3, CD79a and BLA-36 and for class II molecules of the major histocompatability complex. The cats ranged in age from 4-16 years (median 10.5 years). The main presenting clinical signs were vomiting, diarrhoea and weight loss. The majority of alimentary lymphomas were of the B-cell type (n=15), whereas cases of T-cell lymphoma were fewer in number (n=8). Four cats had lymphoma of a mixed T-and B-cell phenotype. In five of the cats, immunohistochemistry suggested an inflammatory process, in contradiction to the original histopathological diagnosis of lymphoma. Immunolabelling would appear to be a useful adjunct to histopathology in classifying cases of feline alimentary lymphoma, and may help in distinguishing lymphoma from severe intestinal inflammation.
Collapse
Affiliation(s)
- N E Waly
- Division of Companion Animals, School of Clinical Veterinary Science, University of Bristol, Langford House, Langford, Bristol BS40 5DU, UK
| | | | | | | |
Collapse
|
29
|
Louwerens M, London CA, Pedersen NC, Lyons LA. Feline Lymphoma in the Post-Feline Leukemia Virus Era. J Vet Intern Med 2005. [DOI: 10.1111/j.1939-1676.2005.tb02703.x] [Citation(s) in RCA: 50] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
30
|
Roca AL, Nash WG, Menninger JC, Murphy WJ, O'Brien SJ. Insertional polymorphisms of endogenous feline leukemia viruses. J Virol 2005; 79:3979-86. [PMID: 15767400 PMCID: PMC1061563 DOI: 10.1128/jvi.79.7.3979-3986.2005] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
The number, chromosomal distribution, and insertional polymorphisms of endogenous feline leukemia viruses (enFeLVs) were determined in four domestic cats (Burmese, Egyptian Mau, Persian, and nonbreed) using fluorescent in situ hybridization and radiation hybrid mapping. Twenty-nine distinct enFeLV loci were detected across 12 of the 18 autosomes. Each cat carried enFeLV at only 9 to 16 of the loci, and many loci were heterozygous for presence of the provirus. Thus, an average of 19 autosomal copies of enFeLV were present per cat diploid genome. Only five of the autosomal enFeLV sites were present in all four cats, and at only one autosomal locus, B4q15, was enFeLV present in both homologues of all four cats. A single enFeLV occurred in the X chromosome of the Burmese cat, while three to five enFeLV proviruses occurred in each Y chromosome. The X chromosome and nine autosomal enFeLV loci were telomeric, suggesting that ectopic recombination between nonhomologous subtelomeres may contribute to enFeLV distribution. Since endogenous FeLVs may affect the infectiousness or pathogenicity of exogenous FeLVs, genomic variation in enFeLVs represents a candidate for genetic influences on FeLV leukemogenesis in cats.
Collapse
Affiliation(s)
- Alfred L Roca
- Laboratory of Genomic Diversity, Basic Research Program, SAIC-Frederick, Maryland, USA.
| | | | | | | | | |
Collapse
|
31
|
Abstract
Gastrointestinal lymphoma is a common cause of anorexia and weight loss in older cats, with or without vomiting or diarrhea. Most cats are feline leukemia virus-negative and feline immunodeficiency virus-negative. Low-grade gastrointestinal lymphoma may be more common than previously thought, and these cats respond better to chemotherapy agents than cats with high-grade lymphoma. The most significant prognostic indicator is initial response to chemotherapy, with cats that survive the initial induction period generally achieving long-term remission. Thus far, investigations into molecular markers and immunophenotyping have failed to identify useful prognostic indicators.
Collapse
Affiliation(s)
- Keith P Richter
- Veterinary Specialty Hospital of San Diego, Post Office Box 9727, 6525 Calle del Nido, Rancho Santa Fe, CA 92067, USA.
| |
Collapse
|
32
|
Ettinger SN. Principles of treatment for feline lymphoma. CLINICAL TECHNIQUES IN SMALL ANIMAL PRACTICE 2003; 18:98-102. [PMID: 12831069 DOI: 10.1053/svms.2003.36623] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Lymphoma is the most commonly diagnosed neoplasm in cats. As feline leukemia virus antigenemia has decreased over the past 15 years, there has been a profound shift in the presence, signalment, and frequency of sites of feline lymphoma in North America. There is variation in anatomic classification systems, but most studies have divided lymphoma into four groups: alimentary, mediastinal, multicentric, or extranodal. Clinical signs and common differential diagnoses for each of the forms are described. Staging allows for evaluation of the extent of disease. As in the dog, lymphoma is a systemic disease in the cat, and chemotherapy is the treatment of choice for most forms. Exceptions are described. In contrast to canine lymphoma, feline lymphoma is generally more challenging and frustrating to treat than canine lymphoma. Response rates are lower, and remission duration is shorter. Fortunately, cats treated with chemotherapy tend to have less toxicity than dogs. Positive prognostic factors are feline leukemia virus-negative, clinically well at time of diagnosis, and response to therapy. Achieving a complete remission is prognostic for survival. Unfortunately, response cannot be predicted before treatment.
Collapse
|
33
|
Affiliation(s)
- R Malik
- University Veterinary Centre Sydney and Diagnostic Services Laboratory, Faculty of Veterinary Science, The University of Sydney, Australia.
| | | | | |
Collapse
|
34
|
Teske E, Straten G, Noort R, Rutteman GR. Chemotherapy with Cyclophosphamide, Vincristine, and Prednisolone (COP) in Cats with Malignant Lymphoma: New Results with an Old Protocol. J Vet Intern Med 2002. [DOI: 10.1111/j.1939-1676.2002.tb02352.x] [Citation(s) in RCA: 102] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
35
|
Gabor LJ, Love DN, Malik R, Canfield PJ. Feline immunodeficiency virus status of Australian cats with lymphosarcoma. Aust Vet J 2001; 79:540-5. [PMID: 11599813 DOI: 10.1111/j.1751-0813.2001.tb10742.x] [Citation(s) in RCA: 53] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
OBJECTIVE To determine the FIV status of Australian cats with lymphosarcoma and relate this to patient characteristics, tumour characteristics (tissue involvement, histological grade and immunophenotype), haematological and serum biochemical values and FeLV status of affected cats. DESIGN Prospective study of 101 client-owned cats with naturally-occurring lymphosarcoma. PROCEDURE Western blot analysis, ELISA and immunochromatography were used to detect FIV antibodies in serum from cats with lymphosarcoma. RESULTS On the basis of Western blot analysis (which was considered the most accurate method for determining FIV status), 50/101 (50%) of cats with naturally-occurring lymphosarcoma were positive for FIV antibodies. Of these 50 cats, 35 had tumours of B-cell phenotype, 13 had T-cell tumours and 2 had tumours classified as non-B/non-T. Tumours from eight of these FIV-positive cats contained FeLV gene sequences, including a 9-month-old cat with FeLV antigenaemia. Compared with FlV-negative cats with lymphosarcoma, FIV-positive cats were more likely to be domestic crossbreds (P = 0.004), male (P = 0.048) and have atypical (especially nasal) forms of lymphosarcoma (P = 0.09). Only 39 of 107 (36%) blood or sera tested using ELISA were positive for FIV antibodies (including 5 false-positives). CONCLUSIONS The prevalence of FIV infection was considerably higher in our cohort of cats compared with series of lymphosarcoma cases from the Northern hemisphere. A positive FIV status was strongly associated with lymphosarcoma in Australian cats and it is possible that this infection may predispose to the development of lymphoid neoplasia. The presence of FIV infection would have been underestimated if commercial kits alone had been used for serology.
Collapse
Affiliation(s)
- L J Gabor
- Department of Veterinary Anatomy and Pathology, The University of Sydney, New South Wales, Australia
| | | | | | | |
Collapse
|
36
|
Gabor LJ, Jackson ML, Trask B, Malik R, Canfield PJ. Feline leukaemia virus status of Australian cats with lymphosarcoma. Aust Vet J 2001; 79:476-81. [PMID: 11549046 DOI: 10.1111/j.1751-0813.2001.tb13017.x] [Citation(s) in RCA: 41] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
OBJECTIVE To determine the FeLV status of sera and tumours from Australian cats with lymphosarcoma in relation to patient characteristics, tumour characteristics (tissue involvement, histological grade and immunophenotype), haematological and biochemical values. DESIGN Prospective study of 107 client-owned cats with naturally-occurring lymphosarcoma. PROCEDURE An ELISA was used to detect FeLV p27 antigen in serum specimens collected from cats with lymphosarcoma. A PCR was used to detect FeLV DNA in formalin-fixed, paraffin-embedded tissue sections containing neoplastic lymphoid cells. The PCR was designed to amplify a highly conserved region of the untranslated long terminal repeat of FeLV provirus. RESULTS Only 2 of 107 cats (2%), for which serum samples were available, were FeLV-positive on the basis of detectable p27 antigen in serum. In contrast, 25 of 97 tumours (26%) contained FeLV DNA. Of the 86 cats for which both PCR and ELISA data were available, 19(22%) had FeLV provirus in their tumours but no detectable circulating FeLV antigen in serum, while 2 (2%) had FeLV provirus and circulating FeLV antigen. FeLV PCR-positive/ELISA-negative cats (19) differed from PCR-negative/ELISA-negative cats (65) in having fewer B-cell tumours (P = 0.06), more non B-/non T-cell tumours (P = 0.02) and comprising fewer non-Siamese/Oriental pure-bred cats (P = 0.03). CONCLUSIONS The prevalence of FeLV antigen or provirus was considerably lower in our cohort of cats compared with studies of lymphosarcoma conducted in the Northern hemisphere. This suggests that factors other than FeLV are important in the development of lymphosarcoma in many Australian cats. No firm conclusions could be drawn concerning whether FeLV provirus contributed to the development of lymphosarcoma in PCR-positive/ELISA-negative cats.
Collapse
MESH Headings
- Animals
- Antigens, Viral/isolation & purification
- Cat Diseases/epidemiology
- Cat Diseases/virology
- Cats
- DNA, Viral/isolation & purification
- Enzyme-Linked Immunosorbent Assay/veterinary
- Gene Products, gag/genetics
- Gene Products, gag/immunology
- Leukemia Virus, Feline/immunology
- Leukemia, Feline/epidemiology
- Leukemia, Feline/virology
- Lymphoma, Non-Hodgkin/epidemiology
- Lymphoma, Non-Hodgkin/veterinary
- Lymphoma, Non-Hodgkin/virology
- New South Wales/epidemiology
- Polymerase Chain Reaction/veterinary
- Prevalence
- Prospective Studies
- Retroviridae Proteins/genetics
- Retroviridae Proteins/immunology
Collapse
Affiliation(s)
- L J Gabor
- Department of Veterinary Anatomy and Pathology, The University of Sydney, New South Wales, Australia
| | | | | | | | | |
Collapse
|
37
|
Wang J, Kyaw-Tanner M, Lee C, Robinson WF. Characterisation of lymphosarcomas in Australian cats using polymerase chain reaction and immunohistochemical examination. Aust Vet J 2001; 79:41-6. [PMID: 11221568 DOI: 10.1111/j.1751-0813.2001.tb10639.x] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
OBJECTIVE To examine tumour tissue of cats with lymphosarcoma for the presence of feline leukaemia virus and feline immunodeficiency virus and analyse the immunophenotype of the tumours. DESIGN A retrospective study of feline lymphosarcoma cases. METHODS Formalin-fixed, paraffin-embedded tumour tissue of 14 feline lymphosarcomas was examined for the presence of feline leukaemia virus and feline immunodeficiency virus by polymerase chain reaction and immunohistochemistry. Using polyclonal and monoclonal antibodies against T and B lymphocytes, the phenotypic expression of the tumours was characterised. RESULTS No feline leukaemia virus antigen or proviral sequences were detected. Feline immunodeficiency virus proviral sequences were detected in two cases by polymerase chain reaction. Immunophenotyping of all 14 cases resulted in seven cases being classified as B-cell phenotype, four as T-cell phenotype, and the remaining three undetermined. CONCLUSIONS In contrast to previous reports overseas, our results suggest that feline leukaemia virus infection appears to be an infrequent cause of lymphosarcoma in the cats that were necropsied. Feline immunodeficiency virus may have a role in lymphomagenesis. The potential role of feline immunodeficiency virus needs to be explored in more depth. Compared with most previous reports, B-cell tumours were more common than T-cell tumours in this series of cats.
Collapse
Affiliation(s)
- J Wang
- School of Veterinary Science, University of Queensland, Brisbane, Queensland 4072
| | | | | | | |
Collapse
|
38
|
Gabor LJ, Canfield PJ, Malik R. Haematological and biochemical findings in cats in Australia with lymphosarcoma. Aust Vet J 2000; 78:456-61. [PMID: 10923176 DOI: 10.1111/j.1751-0813.2000.tb11856.x] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
OBJECTIVE To describe, for the first time, haematological and serum biochemical findings in cases of lymphosarcoma in Australian cats. DESIGN A prospective multi-institutional study. PROCEDURE Of 118 affected cats presented to the authors over a 18-month period, 97 were evaluated haematologically and 87 biochemically. Haematological analysis usually included determination of packed cell volume, haemoglobin concentration, red blood cell and leukocyte counts, differential leukcocyte count, reticulocyte count and examination of buffycoat smears for neoplastic cells. Serum biochemical analysis was done primarily with a discrete analyser and included a panel of commonly used analytes. RESULTS Nonregenerative anaemia was present in 54% (52/97) of cats. Neutrophilia, present in 65% (59/91) of cats, was commonly associated with lymphocytopaenia, eosinopaenia and monocytosis. Of the 13 cats with a secondary leukaemic manifestation, only five had distinct lymphocytosis. Serum biochemical abnormalities either were nonspecific, such as hypoglycaemia in 37% (32/87) of cats, or related to specific tissue involvement, such as hypoalbuminaemia in 76% (31/41) of cats with alimentary involvement and azotaemia in 60% (15/25) of cats with renal involvement. CONCLUSION It was shown for the first time that haematological and serum biochemical findings are of limited value in diagnosing lymphosarcoma in Australian cats, except if they are leukaemic. Although clinical pathological changes were common, they were nonspecific or related to specific tissue involvement. Their value in assessing response to therapy needs to be examined further. Patient characteristics such as age, breed and sex also had limited effect on laboratory findings and those observed were of little consequence. Additionally, histological and immunophenotypical variations in tumour type had little effect on laboratory findings.
Collapse
Affiliation(s)
- L J Gabor
- Department of Veterinary Clinical Sciences, Faculty of Veterinary Science, University of Sydney, New South Wales
| | | | | |
Collapse
|
39
|
Gunn-Moore DA, Day MJ, Graham ME, Cue SM, Harbour DA. Immune-mediated haemolytic anaemia in two sibling cats associated with multicentric lymphoblastic infiltration. J Feline Med Surg 1999; 1:209-14. [PMID: 11714237 DOI: 10.1053/jfms.1999.0043] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Immune-mediated haemolytic anaemia associated with multicentric lymphoblastic infiltration is reported in two sibling cats. Both cats presented at under 16 months of age with clinical signs of acute anaemia. In each case there was autoagglutination, a positive Coombs' test and the anaemia was regenerative. At presentation, both cats were negative for FeLV antigen. In each case, the disease proved fatal within 2 months of the initial diagnosis. In both cases, T-lymphoblastic infiltration of bone marrow, liver and spleen was found at post-mortem examination.
Collapse
Affiliation(s)
- D A Gunn-Moore
- Department of Pathology and Microbiology, University of Bristol, Langford, BS40 5DU, UK
| | | | | | | | | |
Collapse
|
40
|
Abstract
OBJECTIVE To determine the efficacy of doxorubicin when used alone in inducing remission in cats with lymphosarcoma. DESIGN Prospective multi-institutional study of naturally occurring disease. METHODS Cases were accrued from veterinary institutions in Australia and New Zealand after obtaining consent from informed owners. Cats were treated with doxorubicin every 3 weeks for three treatments. If there was no response to the first dose of doxorubicin or if the cat relapsed during the doxorubicin regimen, the cat was withdrawn from the trial and either euthanased or treated with other agents. Age, breed, gender and anatomic site of the lymphosarcoma (multicentric, alimentary, mediastinal, extranodal) were recorded for each cat. Clinical remission was assessed before each treatment by physical examination, radiography, ultrasonography and computed tomography where appropriate. Complete remission was defined as the disappearance of all clinical signs and clinically detectable tumour. RESULTS Twenty-one cases were accrued over a 2-year-period but only 19 were available for data analysis. Young Siamese cats were over-represented and all cats with mediastinal tumours were young Siamese. There was a significant difference between the mean ages of cats with mediastinal or multicentric lymphosarcoma (mean +/- SD: 3.5 +/- 3.0 and 4.3 +/- 2.6 years, respectively) and cats with alimentary or extranodal LSA (11.4 +/- 0.9 and 11.0 +/- 0.9 years, respectively). Of 19 cats treated with doxorubicin alone, 6 (32%) had complete remission, 6 (32%) had partial remission and 7 (36%) did not respond. CONCLUSIONS The results suggest that doxorubicin cannot be recommended as a single agent for treatment of feline lymphosarcoma because of the rather poor remission rate achieved.
Collapse
Affiliation(s)
- A E Peaston
- Children's Cancer Research Institute, Sydney Children's Hospital, Randwick, New South Wales
| | | |
Collapse
|
41
|
Abstract
OBJECTIVE To determine patients' characteristics and anatomical distribution of lesions in cats with lymphosarcoma. DESIGN Prospective multi-institutional study of naturally occurring feline lymphosarcoma. METHODS Veterinarians in Sydney were provided with free diagnostic laboratory services for suspect cases of feline lymphosarcoma. Lymphosarcoma was diagnosed based on physical findings, radiographic and/or ultrasonographic images and results of cytological or histopathological examination. When owners were not interested in pursuing an antemortem diagnosis, suspect cases were collected for necropsy. Patients' characteristics and physical findings were recorded. A modified scheme for anatomical classification of lesions was devised including a 'mixed' category for cases which involved two or more anatomical forms. RESULTS One hundred and eighteen cases were accrued over an 18 month period. The median age was 120 months and range 5 to 212 months. Age distribution was bimodal, with a small peak for cats less than 24 months, and a normal distribution centred on 97 to 120 months. Eighty cats were domestic crossbreds, 22 were Siamese or Oriental cats (including crosses), 6 were Burmese, 5 were purebred longhairs and the remaining 5 were one of a number of purebred shorthaired breeds. In comparison to 1017 consecutive cases admitted to our hospital for conditions other than lymphosarcoma, Siamese/Oriental cats were over-represented amongst lymphosarcoma cases (P = 0.0006). Male cats were also over-represented, accounting for 72 of 118 cases (P = 0.05). Abdominal lymphosarcoma was the most common anatomical form (43 cats), followed by mixed (39), nodal (20), mediastinal (9) and atypical (involving non-lymphoid organs, 7) forms. When analysed for specific organ involvement, 29 (25%) had mediastinal involvement, 71 (60%) had abdominal involvement including 60 (51%) with involvement of the intestinal tract and/or mesenteric lymph nodes and 36 (31%) with bilateral renal involvement, and 47 (40%) had peripheral lymph node involvement. No case of primary lymphoid leukaemia was identified. A noticeable subgroup of cats younger than 24 months had involvement of the anterior mediastinum with or without concurrent enlargement of cervical or axillary lymph nodes; Siamese/Oriental cats were over-represented in this subgroup. Among cases with nodal involvement, lymph nodes of the head and neck were frequently involved, mandibular nodes most commonly, followed by superficial cervical nodes. In seven cases a solitary node was affected. CONCLUSIONS Compared with similar surveys overseas, our cats were older and male cats were over-represented. There was a notable subgroup of young cats with mediastinal involvement. Siamese/Oriental cats were over-represented in this subgroup as well as in the larger population of cats with lymphosarcoma. Compared with overseas surveys, renal involvement, mixed cases and atypical cases (including nasal lymphosarcoma) were more common. A new subcategory of nodal lymphosarcoma, with involvement restricted to node(s) of head and neck, was identified.
Collapse
Affiliation(s)
- L J Gabor
- Department of Veterinary Anatomy and Pathology, Faculty of Veterinary Science, University of Sydney, New South Wales
| | | | | |
Collapse
|
42
|
Beatty JA, Lawrence CE, Callanan JJ, Grant CK, Gault EA, Neil JC, Jarrett O. Feline immunodeficiency virus (FIV)-associated lymphoma: a potential role for immune dysfunction in tumourigenesis. Vet Immunol Immunopathol 1998; 65:309-22. [PMID: 9839882 DOI: 10.1016/s0165-2427(98)00164-0] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
To determine the potential role of immune dysfunction in feline immunodeficiency virus (FIV)-associated lymphomagenesis, we present the results of immunological monitoring during the chronic phase of experimental FIV infection in two cats which subsequently developed lymphoma. In one cat, C1, cell-mediated immunity was depressed throughout the monitoring period but particularly from 125-200 weeks post-infection (pi), when this cat demonstrated profoundly impaired lymphocyte blastogenesis and markedly increased interleukin-1 (IL-1) production compared to age-matched, uninfected control cats. Lymphocyte function in the other cat, C2, was preserved to a greater degree. Alterations in the levels of immunoglobulin isotypes M, A and G in CD4+-, CD8+- and CD21+-lymphocyte sub-sets were demonstrated in both cats. Southern blot analysis revealed the presence of integrated FIV-provirus in tumour DNA from C2 but not C1 indicating a possible direct role for the virus in the former case only. In this study we have characterised, for the first time, the FIV-induced immune dysfunction in cats which developed lymphoma, demonstrating potential indirect mechanisms of tumourigenesis.
Collapse
Affiliation(s)
- J A Beatty
- Department of Veterinary Clinical Sciences, University of Sydney, NSW, Australia
| | | | | | | | | | | | | |
Collapse
|